Severity of Dysmenorrhea and Endometrioma 2006
-
Upload
syukrinaalvi -
Category
Documents
-
view
218 -
download
0
description
Transcript of Severity of Dysmenorrhea and Endometrioma 2006
-
ORIGINAL ARTICLE
Relation between severity of dysmenorrhea and endometrioma
NICOLAS CHOPIN, MARCOS BALLESTER, BRUNO BORGHESE, ARNAUD
FAUCONNIER, HERVE FOULOT, CECILE MALARTIC & CHARLES CHAPRON
Universite Rene Descartes (Paris V); Assistance Publique Hopitaux de Paris (AP-HP); Groupe Hospitalier UniversitaireOuest; Service de Gynecologie Obstetrique et Medecine de la Reproduction (Pr Chapron), Unite de Chirurgie Gynecologique,
CHU Cochin, Paris, France
AbstractBackground . To evaluate the relationship between the severity of dysmenorrhea and endometrioma. Methods. Descriptivestudy with prospective design. Two hundred and thirty-nine women with histologically proved endometriomas. The severityof dysmenorrhea was assessed prospectively with a 10-cm visual analog scale. Various indicators concerning theendometrioma and the extent of deep infiltrating endometriosis were recorded during surgery in 239 patients. Correlationswere sought with a multiple regression logistic model. Results. According to univariate analysis, the following variables wererelated to more severe dysmenorrhea: subperitoneal infiltration (uterosacral ligament and rectal infiltration) and R-AFSscore of implants. None of the specific characteristics of endometriomas were associated with severe dysmenorrhea. Aftermultiple regression analysis, rectal infiltration and R-AFS score of implants were the only factors that remained related todysmenorrhea severity. Conclusions. When there is an endometrioma, severe dysmenorrhea is not directly related with thecharacteristics specific to these ovarian cysts. The associated deep infiltrating endometriotic lesions and in particular rectalinfiltration could explain these symptoms.
Key words: Endometrioma, deep infiltrating endometriosis, pelvic pain, dysmenorrhea
Deeply infiltrating endometriosis (DIE) is a specific
affliction responsible for painful functional symp-
toms, sometimes associated with infertility (1,2).
The types of pelvic pain (dysmenorrhea (DM), deep
dyspareunia, non-cyclic chronic pelvic pain, lower
urinary and gastrointestinal symptoms) are related to
the anatomic location of DIE (3). DM is very
common in the general population (4) and is
especially frequent in women with endometriosis
(5). Endometriosis is frequently located on the ovary
and tends to be associated with other sites affected
by the disease (6). In the case of DIE, the intensity of
the pain is recognized as being proportional to the
depth to which the lesions penetrate (1,7,8). The
factors described as being responsible for pelvic pain
in case of endometriomas are not clearly defined
(1,712). Most studies address all types of endome-triotic lesions without drawing any distinction be-
tween DIE and other types of endometriosis. Their
inclusion criteria are generally the existence of
painful symptoms or infertility, resulting in a hetero-
geneous population of patients who do not necessa-
rily present any endometriotic cyst.
Our aim is to clarify which factors and which
characteristics of endometriotic cysts are responsible
for severe DM, working on a prospective basis with a
homogeneous population of patients with endome-
triomas.
Materials and methods
Population study
This descriptive study with a prospective design
includes all the women presenting an endometrioma
who underwent surgery for pelvic pain symptoms
between January 2000 and December 2003. This
Correspondence: Charles Chapron, Service de Gynecologie Obstetrique II, Clinique Universitaire Baudelocque, 123 Bld Port-Royal, 75014 Paris, France.
E-mail: [email protected]
Acta Obstetricia et Gynecologica. 2006; 85: 13751380
(Received 21 February 2006; accepted 22 July 2006)
ISSN 0001-6349 print/ISSN 1600-0412 online # 2006 Taylor & FrancisDOI: 10.1080/00016340600935490
-
selection was made during the diagnostic phase and
was based on preoperative ultrasound examination
revealing an endometrioma of over 2 cm. Only
histologically proved endometriomas were included.
Endometriotic lesions were considered histologically
confirmed when endometrial glands and stroma
were present at microscopic examination.
Variables
DM intensity was assessed prospectively with a 10-
cm visual analog scale reading recorded during the
month before surgery by means of a self-assessment
questionnaire. Severe DM was defined as a pain
score of 7 or above on the linear scale (13). The
patients characteristics (age, height, weight, body
mass index (BMI) (kg/m2), parity, history of medical
or laparoscopic treatment for endometriosis) were
recorded. Concerning the endometriomas, the fol-
lowing characteristics were recorded: number of
endometriomas, mean size of each in case of multi-
ple locations, laterality, and CA-125 level.
Associated endometriotic lesions were superficial
peritoneal endometriosis, DIE, adnexal adhesions,
and Douglas pouch adhesions (absent, partial ob-
literation, complete obliteration). The disease stage
was scored according to the revised American
Fertility Society classification (14) and subscores
for implants and adhesions were also recorded.
Anatomic locations of DIE-associated nodules were
coded according to a previously published classifica-
tion (15). According to this classification, patients
were classed in four groups according to the location
of the DIE lesions: uterosacral ligament (USL),
when lesions infiltrated the USL(s) only; vagina,
when lesions infiltrated the anterior rectovaginal
pouch, posterior vaginal fornix, and retroperitoneal
area between the anterior rectovaginal pouch and the
posterior vaginal fornix; bladder, when lesions
infiltrated the bladder muscularis propria; and in-
testine, when lesions involved the muscularis pro-
pria of the bowel. When there were several locations
in the same patient, she was classed in the group for
the lesion that was considered to be the most severe.
By definition, the increasing order of severity was the
following: USL, vagina, bladder, intestine.
Statistical analysis
Women with severe DM were compared with the
other patients. For univariate statistical analysis we
used the following tests: Pearsons chi-square test for
qualitative variables or Fishers exact test as appro-
priate; paired Students t-test for quantitative
variables or Wilcoxon signed-rank as appropriate.
We used the KruskalWallis test to compare multi-ple quantitative variables. Subsequently, the vari-
ables associated with severe DM at the threshold of
p/0.20 in univariate analysis were tested in amultiple logistic regression model. A final model
was constructed including only those variables
independently associated with severe DM at the
threshold of B/0.05. The parameter values of thefinal model were estimated by the maximum like-
lihood method, and adjusted odds ratios and their
confidence intervals calculated from the models
coefficients and their standard deviations.
Results
During the study period, 310 patients presenting a
histologically proven endometrioma measuring
over 20 mm and pelvic pain were operated. Se-
venty-one (22.9%) were excluded for the following
reasons: amenorrhea and menopausal status 11cases (3.6%); failure to respond to the questionnaire
60 cases (19.4%). The final study populationincluded 239 women (77.1%).
Out of the 239 patients eligible, the mean value of
the visual analog DM scale reading was 5.19/3.2.The symptoms were distributed as follows: 154
patients had DMB/7/10 and 85 women had DM]/7/10. Their mean values were 3.39/2.6 and 8.39/1.1respectively (Table I). Among these 239 women, 211
(88.3%) presented endometrioma(s) only versus 28
(11.7%) associated DIE lesions. Their DM scales
were 5.19/3.2 versus 5.59/3.3; p/0.37.Disease stage was scored according to the R-AFS
classification and details of the scores are reported in
Table II.
After univariate analysis the following variables
were related to more severe DM: subperitoneal
infiltration (USL and rectal infiltration) and R-AFS
score of implants (Table III). None of the specific
characteristics of endometriomas were associated
with severe DM.
After multiple regression analysis, rectal infiltra-
tion and R-AFS score of implants above 26 were the
only factors that remained related to DM severity
(Table III).
Discussion
While it is accepted that there is an association
between DM and endometriosis (16), the data in the
literature concerning the painful physiopathology of
endometriotic cysts are heterogeneous, few in num-
ber and contradictory (1,712).Our aim is to clarify which factors and which
characteristics of endometriotic cysts are responsible
1376 N. Chopin et al.
-
Table I. Patients characteristics according to the severity of their dysmenorrhea.
DMB/7/10 (n/154 patients) DM]/7/10 (n/85 patients)
Variables Mean9/SD (extremes) n (%) Mean9/SD (extremes) n (%) p
Intensity of dysmenorrhea 3.39/2.6 (0/6.9) 8.39/1.1 (7/10)Patients characteristics
Age (year) 35.19/7.8 (20.5/49.8) 34.89/7.4 (17.4/49.0) 0.72a
Weight (kg) 59.59/10.7 (42/103) 58.89/9.3 (42/89) 0.32a
Height (cm) 165.59/7.2 (148/186) 164.59/6.3 (151/182) 0.64a
No. pregnancies
0 126 (81.8) 66 (77.7)
1 14 (9.1) 11 (12.9)
]/2 14 (9.1) 8 (9.4) 0.48b
History of treatment for endometriosis
Laparoscopic treatment
0 101 (66.0) 48 (56.5)
12 48 (31.3) 32 (37.7)]/3 4 (2.61) 5 (5.9) 0.14b
Hormonal treatment
Progestational hormones 55 (36.4) 24 (29.6)
LH-RH analogs 28 (18.5) 26 (32.1)
Other 2 (1.3) 1 (1.2) 0.13c
Anatomic location and number of deeply infiltrating endometriosis
Bladder
No 153 (99.4) 84 (98.8)
Yes 1 (0.7) 1 (1.2) 1b
USL
No 135 (87.7) 72 (84.7)
Yes 19 (12.3) 13 (15.3) 0.03b
Vagina
No 51 (98.1) 79 (92.9)
Yes 3 (2.0) 6 (7.1) 0.07b
Rectum
No 153 (99.4) 78 (91.8)
Yes 1 (0.7) 7 (8.2) 0.003b
Total number of lesions
0 143 (92.9) 68 (80.0)
1 5 (3.3) 7 (8.2)
2 5 (3.3) 4 (4.7)
3 1 (0.7) 1 (1.2)
4 1 (1.2)
5 1 (1.2)
6 2 (2.4)
7 1 (1.2) 0.003c
Endometrioma characteristics
No. of endometriomas 1.49/0.6 (1.0/4.0) 1.69/0.8 (1.0/5.0) 0.36d
Size of endometrioma no. 1 (mm) 43.89/26.6 (20.0/250.0) 40.29/17.8 (4.0/100.0) 0.68d
Size of endometrioma no. 2 (mm)* 27.49/13.5 (5.0/80.0) 29.59/14.9 (15.0/80.0) 0.65d
Laterality
Right 36 (23.38) 22 (25.88)
Left 80 (51.95) 34 (40.00)
Bilateral 38 (24.68) 29 (34.12) 0.17e
CA-125 assay (UI/ml) 61.79/78.6 (5.0/563.0) 629/54.8 (8.0/238.0) 0.39d
aStudents t -test.bKruskalWallis test.cFishers exact test.dWilcoxon test.ej2 test.
*Size of endometrioma no. 2 is size of second endometrioma when there are bilateral cysts (the smaller of the two cysts being taken by
convention as endometrioma no. 2).
Relation between severity of dysmenorrhea and endometrioma 1377
-
for severe DM working on a homogeneous painful
population of patients with endometriomas. To our
knowledge no study has addressed a homogeneous
population of patients with endometriomas on a
prospective basis.
Our study found two independent factors asso-
ciated with severe DM: rAFS score for implants
exceeding 26 and the presence of associated deeply
infiltrating rectal endometriosis.
The specific characteristics of the endometriomas
do not appear to be correlated with the severity of
the DM. The innervation characteristics of endome-
triomas could explain this finding. Nerve infiltration
by deeply infiltrating endometriotic lesions has been
shown to correlate with the severity of DM. This
association has been clearly demonstrated in case of
vaginal or GI tract lesions, and implants that
penetrate the wall of adjacent organs have closer
relationships with nerve fibers than those that do not
(13,17). Unlike the case for these lesions, there are
Table II. Severity of dysmenorrhea according to the revised American Fertility Society Classification (14).
DMB/7/10 (n/154 patients) DM]/7/10 (n/85 patients)
Variable Mean9/SD (extremes) n (%) Mean9/SD (extremes) n (%) p
AFS superficial peritoneum 0.68a
0 93 (61.2) 51 (60.0)
1 3 (2.0) 0 (0.0)
2 16 (10.5) 9 (10.6)
4 35 (23.0) 20 (23.5)
6 5 (3.3) 5 (5.9)
AFS deep peritoneum 0.19a
0 112 (73.7) 57 (67.1)
2 6 (4.0) 1 (1.2)
4 21 (13.8) 14 (16.5)
6 12 (7.9) 13 (15.3)
16 1 (0.7) 0 (0.0)
AFS total implants 25.29/8.0 (16/46) 28.09/9.4 (10.0/46.0) 0.01b
Right ovary adhesions 0.73a
0 54 (35.3) 28 (32.9)
1 19 (12.4) 5 (5.9)
2 8 (5.2) 6 (7.1)
4 14 (9.2) 17 (20.0)
8 39 (25.5) 18 (21.2)
16 19 (12.4) 11 (12.9)
Left ovary adhesions 0.22a
0 39 (25.5) 17 (20.0)
1 13 (8.5) 8 (9.4)
2 10 (6.5) 2 (2.4)
4 25 (16.3) 17 (20.0)
8 44 (28.8) 24 (28.2)
16 22 (14.4) 17 (20.0)
AFS Douglas 0.99a
0 90 (58.8) 48 (57.1)
4 27 (17.7) 19 (22.6)
40 36 (23.5) 17 (20.2)
AFS total adhesions 23.89/27.7 (0.0/104.0) 25.99/28.9 (0.0/104.0) 0.23b
AFS total (implants/adhesions) 49.09/31.5 (16.0/150.0) 53.99/33.7 (14.0/150.0) 0.13b
aKruskalWallis test.bWilcoxon test.
Table III. Determinants for severity of DM results from multiple
logistic regression analysis.
Independent variable Adj OR for severity of DM 95% CI
Rectal infiltration
Yes 1 No 0.082 0.0100.687
Score rAFS implants*
]/24 1 B/24 0.521 0.3000.905
CI, confidence interval.
*Score according to the revised American Fertility Society
Classification (14).
1378 N. Chopin et al.
-
no nerve fibers to be found in endometriomas (18),
which may be the reason why these cysts are not very
painful. Two studies only found a correlation be-
tween DM and the presence of endometriomas
(12,19). Fedele et al. found an association between
unilateral or bilateral endometriomas and the sever-
ity of DM. Muzii et al. described a correlation
between the presence of an endometriotic cyst and
the severity of DM. On the contrary, for Vercellini
et al. (10) DM was less frequent in patients with
ovarian endometriosis only, than in those with
associated lesions at other sites. Porpora et al. (8)
found an association between DM and endometrio-
mas by univariate analysis. This relationship would
seem to disappear after adjustment, and analysis
suggests that this pain is related to periovarian
adhesions rather than to the cyst itself. The physio-
pathological mechanism by which these periadnexal
adhesions might be associated with DM remains
unclear. Similar results have been reported by other
authors (10,20).
Our results, concerning rectal involvement as an
independent factor correlated with the severity of
DM in the case of endometrioma, appear to confirm
the results of earlier works (7). Although the initial
population in this study concerned patients with
DIE with or without specific ovarian endometriotic
lesions, the authors had already revealed an associa-
tion between the severity of DM and the depth of
posterior subperitoneal disease involvement. One of
the hypotheses evoked was the correlation between
compression or infiltration of the nerves by these
endometriotic lesions in the subperitoneal pelvic
space, in particular in the posterior area (20).
For Redwine (6), deep involvement of the bowel is
significantly greater in patients presenting an en-
dometrioma. Moreover, whether in the presence of
an endometrioma or not, many studies have found a
link between the intensity of DM and the extent of
the disease measured by the rAFS score (12,19,21),
the number of endometriotic implants, or the pre-
sence of associated deeply infiltrating lesions (11).
So, in agreement with those of other authors, our
results show that in cases of severe DM, the
existence of an endometrioma suggests more diffuse
and in particular subperitoneal presence of endome-
triotic disease involvement. But it is important to
underline that with respect to the rAFS score for
implants these results remain difficult to interpret.
This is because the weighting associated with an
endometriotic cyst in this classification system is
particularly high, with a score of at least 16 in case of
a cyst measuring over 2 cm and at least 20 in case of
a cyst measuring over 3 cm. To this score for the
cystic implants is then added the score for any
associated deeply infiltrating lesions. All our patients
had at least one endometrioma over 2 cm in size. So
in our study the implant score tends necessarily to
reach a high figure without it being possible,
unfortunately, to know whether this is due to the
presence of the cyst or the associated lesions. As
already mentioned, these results underline the limits
of the rAFS classification with respect to DIE
(10,22). The score was initially proposed for patients
presenting with infertility in a context of endome-
triosis without taking the problem of pelvic pain into
account when scoring deep endometriotic lesions.
Such lesions appear to be underestimated. In the
case of endometrioma the score is overestimated.
Our results show that endometriomas as such are
not much involved in the genesis of DM. The pain is
most probably secondary to the presence of asso-
ciated subperitoneal lesions, and rectal lesions in
particular. The existence of an endometriotic cyst
when there is severe DM would appear to form part
of a more diffuse endometriotic disease context. It
justifies a preoperative search for the exact location
of possible associated deeply infiltrating lesions by
precise questioning, perimenstrual clinical examina-
tion, and possibly an in-depth imaging work-up.
Acknowledgements
The authors thank Aventis-Synthelabo Laboratories
(France) for providing technical assistance in statis-
tical analysis.
References
1. Koninckx PR, Meuleman C, Demeyere S, Lesaffre E,
Cornillie FJ. Suggestive evidence that pelvic endometriosis
is a progressive disease, whereas deeply infiltrating endome-
triosis is associated with pelvic pain. Fertil Steril. 1991;/55:/
75965.2. Fauconnier A, Chapron C. Endometriosis and pelvic pain:
epidemiological evidence of the relationship and implications.
Hum Reprod Update. 2005;/11:/595605.3. Fauconnier A, Chapron C, Dubuisson JB, Vieira M, Dousset
B, Breart G. Relation between pain symptoms and the
anatomic location of deep infiltrating endometriosis. Fertil
Steril. 2002;/78:/71926.4. Jamieson DJ, Steege JF. The prevalence of dysmenorrhea,
dyspareunia, pelvic pain, and irritable bowel syndrome in
primary care practices. Obstet Gynecol. 1996;/87:/558.5. Al-Badawi IA, Fluker MR, Bebbington MW. Diagnostic
laparoscopy in infertile women with normal hysterosalpingo-
grams. J Reprod Med. 1999;/44:/9537.6. Redwine DB. Ovarian endometriosis: a marker for more
extensive pelvic and intestinal disease. Fertil Steril. 1999;/72:/
3105.7. Chapron C, Fauconnier A, Dubuisson JB, Barakat H, Vieira
M, Breart G. Deeply infiltrating endometriosis: relation
between severity of dysmenorrhea and extent of the disease.
Hum Reprod. 2003;/18:/7606.
Relation between severity of dysmenorrhea and endometrioma 1379
-
8. Porpora MG, Koninckx PR, Piazze J, Natili M, Colagrande S,
Cosmi EV. Correlation between endometriosis and pelvic
pain. J Am Assoc Gynecol Laparosc. 1999;/6:/42934.9. Muzii L, Marana R, Pedulla S, Catalano GF, Mancuso S.
Correlation between endometriosis-associated dysmenorrhea
and the presence of typical or atypical lesions. Fertil Steril.
1997;/68:/1922.10. Vercellini P, Trespidi L, De Giorgi O, Cortesi I, Parazzini F,
Crosignani PG. Endometriosis and pelvic pain: relation to
disease stage and localization. Fertil Steril. 1996;/65:/299304.11. Perper MM, Nezhat F, Goldstein H, Nezhat CH, Nezhat C.
Dysmenorrhea is related to the number of implants in
endometriosis patients. Fertil Steril. 1995;/63:/5003.12. Fedele L, Bianchi S, Bocciolone L, Di Nola G, Parazzini F.
Pain symptoms associated with endometriosis. Obstet Gyne-
col. 1992;/79:/7679.13. Anaf V, Simon P, El Nakadi I, Fayt I, Buxant F, Simonart T,
et al. Relationship between endometriotic foci and nerves in
rectovaginal endometriosis nodules. Hum Reprod. 2000;/15:/
174450.14. AFS. Revised American Fertility Society classification of
endometriosis: 1985. Fertil Steril. 1985;/43:/3512.15. Chapron C, Fauconnier A, Vieira M, Barakat H, Dousset B,
Pansini V, et al. Anatomic distribution of deeply infiltrating
endometriosis: Surgical implications and proposition for a
classification. Hum Reprod. 2003;/18:/15761.
16. Vercellini P. Endometriosis: what a pain it is. Semin Reprod
Endocrinol. 1997;/15:/25161.17. Anaf V, El Nakadi I, Simon P, Van De Stadt J, Fayt I,
Simonart T, et al. Preferential infiltration of large bowel
endometriosis along the nerves of the colon. Hum Reprod.
2004;/19:/9961002.18. Al-Fozan H, Bakare S, Chen MF, Tulandi T. Nerve fibers in
ovarian dermoid cysts and endometriomas. Fertil Steril.
2004;/82:/2301.19. Muzii L, Marana R, Caruana P, Mancuso S. The impact of
preoperative gonadotropin-releasing hormone agonist treat-
ment on laparoscopic excision of ovarian endometriotic cysts.
Fertil Steril. 1996;/65:/12357.20. Anaf V, Simon P, El Nakadi I, Simonart T, Noel JC, Buxant
F. Impact of surgical resection of rectovaginal pouch of
Douglas endometriotic nodules on pelvic pain and some
elements of patients sex life. J Am Assoc Gynecol Laparosc.
2001;/8:/5560.21. Buttram VC Jr. Conservative surgery for endometriosis in the
infertile female: a study of 206 patients with implications for
both medical and surgical therapy. Fertil Steril. 1979;/31:/
11723.22. Dubuisson JB, Chapron C. Classification of endometriosis:
The need for modification. Hum Reprod. 1994;/9:/22146.
1380 N. Chopin et al.